Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Bispecific CD20-directed CD3 T Cell Engager [EPC]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Drug	Reports	Deaths	Death Rate	Hosp.	Life-Threat.	Avg Age	% Female
EPCORITAMAB	2,041	430	21.1%	1,652	229	67.5 yrs	47.5%
GLOFITAMAB	1,116	315	28.2%	492	46	62.5 yrs	53.2%

Head-to-Head Comparisons

EPCORITAMAB vs GLOFITAMAB

← Back to Bispecific CD20-directed CD3 T Cell Engager [EPC] Class side effects →